Prescription drug contains a unique strain of Escherichia coli Nissle 1917 in the amount of 2.5 – 25 * 109 CFU, which, due to its unique anti-inflammatory properties, is the most studied bacterial strain today. Approved for use in pregnant and lactating women, is widely used in Germany and around the world.
Prescription drug, contains a unique strain of Escherichia coli Nissle 1917 in the amount of 108 CFU, approved for use from the 1st day of life in newborns, including premature infants.
The original drug, has a high content of carnitine and lysine, allows for the fast results in treating appetite disorders, asthenia and weight deficit. Metopine contained in the drug, improves appetite and has a calming effect.